Ruchika Bhargav

700 total citations
16 papers, 454 citations indexed

About

Ruchika Bhargav is a scholar working on Infectious Diseases, Neurology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ruchika Bhargav has authored 16 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 6 papers in Neurology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ruchika Bhargav's work include COVID-19 Clinical Research Studies (11 papers), Long-Term Effects of COVID-19 (6 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Ruchika Bhargav is often cited by papers focused on COVID-19 Clinical Research Studies (11 papers), Long-Term Effects of COVID-19 (6 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Ruchika Bhargav collaborates with scholars based in United States and Canada. Ruchika Bhargav's co-authors include Kevin Bryan Lo, Grace Salacup, Jerald Pelayo, Jeri Albano, Zurab Azmaiparashvili, Gabriel Patarroyo‐Aponte, Janani Rangaswami, Fahad Gul, Robert DeJoy and Eric Peterson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Journal of Medical Virology.

In The Last Decade

Ruchika Bhargav

15 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruchika Bhargav United States 10 342 158 105 70 65 16 454
Grace Salacup United States 11 340 1.0× 159 1.0× 106 1.0× 63 0.9× 65 1.0× 16 459
Jeri Albano United States 10 385 1.1× 174 1.1× 103 1.0× 64 0.9× 66 1.0× 16 557
Jerald Pelayo United States 11 329 1.0× 147 0.9× 104 1.0× 73 1.0× 65 1.0× 21 469
Zurab Azmaiparashvili United States 11 406 1.2× 186 1.2× 108 1.0× 73 1.0× 66 1.0× 30 585
Robert DeJoy United States 9 283 0.8× 125 0.8× 86 0.8× 62 0.9× 65 1.0× 14 394
Megan Fraissé France 8 229 0.7× 83 0.5× 59 0.6× 117 1.7× 126 1.9× 12 414
Siye Zhang China 9 351 1.0× 145 0.9× 58 0.6× 167 2.4× 13 0.2× 11 575
Chaouki Mezher France 8 229 0.7× 170 1.1× 27 0.3× 226 3.2× 26 0.4× 10 524
Radj Cally France 6 176 0.5× 50 0.3× 31 0.3× 102 1.5× 125 1.9× 13 355
Frederico Bruzzi de Carvalho Brazil 9 112 0.3× 58 0.4× 37 0.4× 193 2.8× 23 0.4× 17 406

Countries citing papers authored by Ruchika Bhargav

Since Specialization
Citations

This map shows the geographic impact of Ruchika Bhargav's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruchika Bhargav with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruchika Bhargav more than expected).

Fields of papers citing papers by Ruchika Bhargav

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruchika Bhargav. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruchika Bhargav. The network helps show where Ruchika Bhargav may publish in the future.

Co-authorship network of co-authors of Ruchika Bhargav

This figure shows the co-authorship network connecting the top 25 collaborators of Ruchika Bhargav. A scholar is included among the top collaborators of Ruchika Bhargav based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruchika Bhargav. Ruchika Bhargav is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bhargav, Ruchika, et al.. (2023). Recurrence of device-related thrombus 3 years after left atrial appendage occlusion. HeartRhythm Case Reports. 10(2). 128–131. 1 indexed citations
2.
Bhargav, Ruchika, et al.. (2023). RECURRENT DEVICE-RELATED THROMBUS AFTER WATCHMAN IMPLANT. Journal of the American College of Cardiology. 81(8). 3243–3243.
3.
DeJoy, Robert, Kevin Bryan Lo, Jeri Albano, et al.. (2021). Association of Pre-Admission Statin Use With Reduced In-Hospital Mortality in COVID-19. The American Journal of the Medical Sciences. 361(6). 725–730. 20 indexed citations
4.
Lo, Kevin Bryan, Ruchika Bhargav, Grace Salacup, et al.. (2021). Factors associated with hospital readmissions among patients with COVID‐19: A single‐center experience. Journal of Medical Virology. 93(9). 5582–5587. 16 indexed citations
5.
Lo, Kevin Bryan, Ruchika Bhargav, Fahad Gul, et al.. (2021). Predictors of venous thromboembolism in patients with COVID‐19 in an underserved urban population: A single tertiary center experience. The Clinical Respiratory Journal. 15(8). 885–891. 2 indexed citations
6.
Lo, Kevin Bryan, Grace Salacup, Jiahui Jiang, et al.. (2021). Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in acute heart failure: invasive hemodynamic parameters and clinical outcomes. Reviews in Cardiovascular Medicine. 22(1). 199–206. 4 indexed citations
7.
Lo, Kevin Bryan, Grace Salacup, Jerald Pelayo, et al.. (2020). Bacterial infections and patterns of antibiotic use in patients with COVID‐19. Journal of Medical Virology. 93(3). 1489–1495. 102 indexed citations
8.
Lo, Kevin Bryan, Ruchika Bhargav, Grace Salacup, et al.. (2020). Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysis. Expert Review of Cardiovascular Therapy. 18(12). 919–930. 23 indexed citations
9.
Lo, Kevin Bryan, Jeri Albano, Eric Peterson, et al.. (2020). Anticoagulation and bleeding risk in patients with COVID-19. Thrombosis Research. 196. 227–230. 72 indexed citations
10.
Lo, Kevin Bryan, Eric Peterson, Robert DeJoy, et al.. (2020). The relationship between diabetes and clinical outcomes in COVID-19: a single-center retrospective analysis. Acta Diabetologica. 58(1). 33–38. 36 indexed citations
11.
Lo, Kevin Bryan, et al.. (2020). Dialysis access as a source of infective endocarditis in dialysis patients. SHILAP Revista de lepidopterología. 90(4). 4 indexed citations
12.
Wiener, Philip C., et al.. (2020). Color Doppler Splay: A Clue to the Presence of Significant Mitral Regurgitation. Journal of the American Society of Echocardiography. 33(10). 1212–1219.e1. 8 indexed citations
13.
Pelayo, Jerald, Kevin Bryan Lo, Ruchika Bhargav, et al.. (2020). Clinical Characteristics and Outcomes of Community- and Hospital-Acquired Acute Kidney Injury with COVID-19 in a US Inner City Hospital System. Cardiorenal Medicine. 10(4). 223–231. 64 indexed citations
14.
Salacup, Grace, Kevin Bryan Lo, Fahad Gul, et al.. (2020). Characteristics and clinical outcomes of COVID‐19 patients in an underserved‐inner city population: A single tertiary center cohort. Journal of Medical Virology. 93(1). 416–423. 54 indexed citations
15.
Peterson, Eric, Kevin Bryan Lo, Robert DeJoy, et al.. (2020). The relationship between coronary artery disease and clinical outcomes in COVID-19: a single-center retrospective analysis. Coronary Artery Disease. 32(5). 367–371. 24 indexed citations
16.
Lo, Kevin Bryan, Grace Salacup, Jerald Pelayo, et al.. (2020). Characteristics of peripheral blood differential counts in hospitalized patients with COVID‐19. European Journal Of Haematology. 105(6). 773–778. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026